Turmeric & Curcumin
The Golden Spice Between Kitchen and Clinic
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
Turmeric is a genuine "mixed evidence" case. The most promising human data are for osteoarthritis: several meta-analyses find oral turmeric/curcumin modestly relieves knee pain and stiffness, and the US NCCIH calls the initial evidence positive while stressing that higher-quality trials are needed. For most of the sweeping claims (cancer prevention, broad disease cure), human evidence is limited and far short of the lab hype, complicated by poor bioavailability and wide variation in product content. Honest summary: as a culinary spice it is safe and pleasant; as a supplement it shows real but modest promise for joint pain and remains unproven for most marketed uses.
Reference only. Not medical advice.
What can go wrong
Turmeric in food is very safe and is treated as such by food-safety regulators. The notable safety signal is with concentrated supplements. A growing number of turmeric and curcumin associated liver-injury cases have been reported internationally, some severe and at least one fatal in the US case series, and high-bioavailability formulations and added piperine appear to raise the risk. NIH LiverTox now classes turmeric as a well-documented cause of clinically apparent liver injury, while still estimating the event as rare. Warning signs include yellowing of the skin or eyes, dark urine, nausea, and stomach pain. Turmeric may also affect blood clotting and can interact with medications. Anyone with liver disease, anyone taking prescription medicines, and anyone who is pregnant or breastfeeding should speak with a qualified healthcare provider before using concentrated turmeric or curcumin supplements, and should stop and seek care if symptoms of liver trouble appear.
Turmeric sits in the gap between traditional reputation and clinical reality, and it does so in both directions. Across South Asia it has been food, medicine, dye, and sacred material for thousands of years, and the trust in the golden spice is enormous. Modern research finds something real but smaller than the marketing: curcumin, the pigment that gives the root its color, is anti-inflammatory in the laboratory, and human trials show modest benefit for knee osteoarthritis pain, while most grander claims stay unproven and are complicated by the fact that curcumin is barely absorbed, which is why products add piperine or special formulations. There is also a turn the tradition could not have seen coming. Turmeric in food is very safe, but concentrated supplements, especially high-absorption versions, have been associated with a rising number of liver-injury cases, some severe. The honest read is a wonderful and safe spice with genuine modest promise for joint pain, oversold for nearly everything else, and a reminder that concentrated and natural is not the same as safe.
An ancient Ayurvedic spice with real but modest evidence for joint pain, hampered by poor absorption, and a surprising liver-injury signal once it's concentrated into supplements.
How it is supposed to work
Curcumin, turmeric's main active compound (only about 3-5% of the rhizome), has anti-inflammatory and antioxidant activity in the lab, acting on multiple inflammatory signaling pathways. A central real-world limitation is bioavailability: curcumin is poorly absorbed and rapidly metabolized, which is why products add piperine (black pepper) or use special formulations to boost absorption, sometimes by thousands of percent.
What people get wrong
Often saidTurmeric supplements are a proven cure for inflammation and a long list of diseases.
ActuallyThe evidence is mixed and mostly modest. Repeated randomized trials support a real reduction in knee osteoarthritis pain, but a 2025 network meta-analysis of 17 trials rated the certainty of that evidence as low, and claims for cancer, depression, and general inflammation rest on small, inconsistent studies. It is associated with benefit for specific joint pain, not established as a cure-all (PMC12309109).
Often saidBecause turmeric is a food, the supplements are automatically safe at any dose.
ActuallyTurmeric in normal food amounts is very safe, but concentrated, high-absorption supplements have been linked to liver injury. The US Drug-Induced Liver Injury Network documented 10 cases, 5 hospitalized and 1 fatal, and NIH LiverTox now lists turmeric as a well-documented cause of clinically apparent liver injury. Natural and concentrated is not the same as safe (PMC9892270, NBK548561).
Often saidAdding piperine or black pepper just helps you absorb more of a harmless compound.
ActuallyPiperine sharply raises curcumin bioavailability by blocking the enzymes that clear it, and several documented liver-injury cases involved products that also contained piperine, raising the possibility that higher exposure contributed to toxicity. More absorption is not automatically more benefit, and it may mean more risk (NBK548561).
Who profits, and who pushes back
US NCCIH (NIH)
Says initial evidence for turmeric/curcumin in osteoarthritis is positive but inconclusive, and warns that highly bioavailable curcumin formulations may harm the liver.
Osteoarthritis meta-analyses
Find oral turmeric/curcumin modestly reduces knee pain and stiffness, while calling for higher-quality trials to confirm.
Hepatology case reports
Document a rising number of turmeric/curcumin-associated drug-induced liver injury cases, often with bioavailability enhancers like piperine.
Supplement marketing
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Promotes turmeric/curcumin as a broad anti-inflammatory cure-all and "superfood," claims that outrun the human evidence, with a clear commercial interest.
Where the research comes from
Most of the published research on this comes from one place. 100% of it is from Used in cooking and medicine across South/SE Asia. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| Used in cooking and medicine across South/SE Asia | 100% |
How we got here
Turmeric was domesticated on the Indian subcontinent, and starch-grain residues consistent with the rhizome have been recovered from cooking and grinding tools at Harappan sites of the Indus Valley dating to around 2500 BCE, placing it among the oldest documented culinary and cosmetic plants of South Asia. By the classical period it was woven into Ayurveda, where it was prized for wound care, digestion, and skin, and into Siddha and Unani practice as well, alongside a ritual and dye role in Hindu ceremony that continues today. Traders carried it west and east, and it reached China and Southeast Asia early, later moving through the Arab world into Europe. For most of that history the root was used whole. Only in the twentieth century was curcumin isolated as the principal colored compound, and only in recent decades did concentrated extracts and bioavailability-boosted supplements turn a kitchen staple into a global wellness product, which is where the modern safety questions begin.
- c. 2500 BCEStarch residues consistent with turmeric found on Harappan-era grinding tools in the Indus Valley
- c. 500 BCETurmeric established within Ayurvedic materia medica for skin, wounds, and digestion
- 1815-1910Curcumin isolated and later characterized chemically by European researchers
- 2004JECFA sets an acceptable daily intake for curcumin of 3 mg/kg body weight
- 2017Nelson and Walters classify curcumin as a PAINS/IMPS compound and note no successful double-blind curcumin trial
- 2022-2023DILIN publishes 10 turmeric liver-injury cases (1 fatal); Australia's TGA issues a turmeric/curcumin liver-injury alert
- 2025Health Canada requires hepatotoxicity warning labels on turmeric and curcumin natural health products
How it is understood
Turmeric (Curcuma longa) has been a cornerstone of Ayurvedic and broader South Asian medicine for thousands of years, valued for wounds, digestion, skin, and inflammation, and woven into food, ritual, and daily life (it colors curries, marks weddings, and features in religious practice). Its place as both spice and medicine, the "food as medicine" ideal, is part of why it feels so trustworthy to so many.
At a glance
- Active compound
- Curcumin (~3-5% of the root)
- Best evidence
- Osteoarthritis (knee) pain, modest
- Key limitation
- Poor bioavailability (piperine added to boost it)
- Safety signal
- Supplement-linked liver injury (rare)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Turmeric & Curcumin. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
Turmeric is a well-documented but rare cause of clinically apparent liver injury; high-bioavailability and piperine-containing products and HLA-B*35:01 raise risk; culinary use distinguished from supplements
DILIN series of 10 turmeric liver-injury cases, 5 hospitalized and 1 fatal, HLA-B*35:01 in 7 of 10, risk tied to piperine and enhanced absorption
Halegoua-De Marzio et al., The American Journal of Medicine (DILIN), PMC
Network meta-analysis, 17 RCTs and 913 participants, turmeric reduces knee OA pain versus placebo but certainty of evidence rated low
Effect of turmeric products on knee osteoarthritis: systematic review and network meta-analysis, PMC
Meta-analytic evidence that curcumin/turmeric efficacy for knee OA pain is comparable to NSAIDs with fewer adverse events
Efficacy of curcuminoids for knee osteoarthritis, systematic review and meta-analysis, PMC
Curcumin classified as PAINS/IMPS; unstable, poorly bioavailable; no successful double-blind placebo-controlled trial as of 2017
Nelson, Walters et al., The Essential Medicinal Chemistry of Curcumin, J. Med. Chem., PMC
Curcumin has poor oral bioavailability; recent pharmacokinetic work questions the large piperine-boost claim
A pharmacokinetic study and critical reappraisal of curcumin formulations, PMC
Australian TGA safety alert: turmeric/curcumin medicines may cause rare liver injury; food amounts safe; higher risk with enhanced-absorption and high-dose products
Health Canada requires hepatotoxicity warning labels on turmeric/curcumin natural health products (Dec 2025)
Turmeric domesticated in South Asia; Indus Valley/Harappan residue evidence; central to Ayurveda
Ethnobotany of turmeric (Curcuma longa L.), Indian Journal of Traditional Knowledge
JECFA/EFSA acceptable daily intake for curcumin of 3 mg/kg body weight/day and safety profile
Turmeric and curcumin bioactive effects and safety profiles review, PMC
Clinical evidence for curcumin in cancer is not strong enough to support therapeutic use; overall/progression-free survival not improved
Curcumin as a complementary treatment in oncological therapy, systematic review, Springer
Curcumin depression/anxiety trials show statistically significant but heterogeneous, low-quality effects requiring larger standardized studies
Curcumin in depression or anxiety: systematic review of mechanistic and clinical evidence, PMC